One Patient's fight: custom stem cells target devastating nerve disease
NCT ID NCT04514952
Summary
This was a special access program for a single patient with ALS (Lou Gehrig's disease). The study tested whether infusions of the patient's own specially processed stem cells, given over 18 weeks, could help control the disease. Doctors closely monitored the patient's symptoms, physical function, and quality of life for a full year to check for safety and any signs of benefit.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for AMYOTROPHIC LATERAL SCLEROSIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
River Oaks Hospital and Clinics
Houston, Texas, 77027, United States
Conditions
Explore the condition pages connected to this study.